Genmab A (GMAB) Non-Current Assets (2018 - 2026)

Genmab A (GMAB) has reported Non-Current Assets for 9 consecutive years, with $9.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 280.34% year-over-year to $9.7 billion; the trailing twelve-month figure through Jun 2026 stood at $29.7 billion (up 257.78% YoY), and the FY2025 full-year result was $10.0 billion, up 497.81% from the prior year.
• Non-Current Assets declined to $9.7 billion in Q2 2026 per GMAB's latest filing, from $9.8 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $10.0 billion in Q4 2025 and bottomed at $185.0 million in Q3 2022.
• Historically, Non-Current Assets has averaged $2.2 billion across 5 years, with a median of $273.0 million in 2023.
• The widest YoY moves for Non-Current Assets: up 1044.36% in 2025, down 86.15% in 2025.
• Over 5 years, Non-Current Assets stood at $330.5 million in 2022, then sank by 38.89% to $202.0 million in 2023, then soared by 727.19% to $1.7 billion in 2024, then surged by 497.81% to $10.0 billion in 2025, then fell by 2.74% to $9.7 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $9.7 billion, $9.8 billion, and $10.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.